Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, Penny Traders Club, Top Penny, bz777, UndervaluedStocks, whento
Search This Board: 
Last Post: 7/22/2017 8:29:28 AM - Followers: 440 - Board type: Free - Posts Today: 4



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the
Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection



About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#49456  Sticky Note Attention all new investors in ARYC!! whento 07/12/17 10:40:46 PM
#48132  Sticky Note For new investors of ARYC. First follow @Arrayit UndervaluedStocks 07/04/17 02:31:34 PM
#47743  Sticky Note Ladies and Gentlemen, as incredulous as it may spotlight1 06/29/17 01:44:26 PM
#46478  Sticky Note We expect an immediate share price increase upon techmover 05/25/17 05:24:04 PM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#50723   Why? Because of the revenues with hugely reputable Toofast 07/22/17 08:29:28 AM
#50722   Look for a moment to this.The SEC reporting winnaar123 07/22/17 08:18:34 AM
#50721   For new investors of ARYC, please do your UndervaluedStocks 07/22/17 04:31:03 AM
#50720   Strong week with great accumulation. Congrats to all UndervaluedStocks 07/22/17 04:00:51 AM
#50719   This stock forgot the company has traded the Meq 07/21/17 09:57:43 PM
#50718   Absolutely. Give it time. Zues 07/21/17 09:17:02 PM
#50717   Chill.... jhols001 07/21/17 08:43:17 PM
#50716   I was told by a member of management Doc Hollywood 07/21/17 07:34:37 PM
#50715   I don't believe that the SEC requires companies MikeCr 07/21/17 07:10:12 PM
#50711   Interesting tweet..doing bsns with 200 bil company Novartis Braden32601 07/21/17 06:12:00 PM
#50710   What a great week...fantastic $ARYC sales and news...financials HighYieldStocks 07/21/17 05:10:12 PM
#50709   Great week!! Happy Weekend Meq 07/21/17 05:06:30 PM
#50707   Great day! Most trades over .016 today! a surfer 07/21/17 04:01:09 PM
#50706   Real companies only PR actual news. I am Gotham Bay Group 07/21/17 03:56:49 PM
#50705   I guess I am sounding like you. So Doc Hollywood 07/21/17 03:51:52 PM
#50704   You're starting to sound like me there Doc! Delsurfer 07/21/17 03:46:34 PM
#50703   OK......?. CHEERS!!!!!!! jrsh 07/21/17 03:43:32 PM
#50702   Well they have to PR the 10k. It Doc Hollywood 07/21/17 03:42:10 PM
#50701   You're right of course but they haven't PRed jrsh 07/21/17 03:32:01 PM
#50700   I don't think a tweet would do anything. Doc Hollywood 07/21/17 03:26:33 PM
#50699   Short conference call with RRBB-less than half hour MikeCr 07/21/17 03:23:50 PM
#50698   They seem to have no interest at all jrsh 07/21/17 03:19:49 PM
#50697   Yeah we saw it but, unfortunately, tweets do Doc Hollywood 07/21/17 03:10:17 PM
#50696   Did you see this? Arrayit receives initial microarray products Penny Traders Club 07/21/17 03:04:40 PM
#50695   Yeah, we are pretty much done trading for Doc Hollywood 07/21/17 03:02:45 PM
#50694   Bid drop... Libra59 07/21/17 03:00:47 PM
#50693   annnd... Any news any news any news??/ are we lloyd Banks 07/21/17 02:55:04 PM
#50692   Now THAT is good news! YAY! ScorpGirl 07/21/17 02:52:14 PM
#50691   Arrayit completes preparation for 10 AM PST final Penny Traders Club 07/21/17 02:49:26 PM
#50689   Summarised ARYC_microarray_business_sales from May - July 2017...p HighYieldStocks 07/21/17 02:34:44 PM
#50688   With the limited volume today and the amount Doc Hollywood 07/21/17 02:30:24 PM
#50687   NEW tweet...Arrayit receives initial microarray products and servi HighYieldStocks 07/21/17 02:29:46 PM
#50686   I hope they not just leave that audit jrsh 07/21/17 02:24:20 PM
#50685   Initial deposit from Novartis suggests more will be Doc Hollywood 07/21/17 02:22:04 PM
#50684   Arrayit receives initial microarray products and services deposit Doc Hollywood 07/21/17 02:19:35 PM
#50683   Profit-taking pause...light volume still - 1.8M Libra59 07/21/17 02:18:25 PM
#50682   #15 Ihub Breakout Board...#13 Most Posted Board... HighYieldStocks 07/21/17 02:12:59 PM
#50681   We´re surfing on new 3Y highs trend HighYieldStocks 07/21/17 02:11:49 PM
#50680   ARYC #16 on breakout boards bz777 07/21/17 02:11:10 PM
#50679   good point. slow and steady upwards we go. whento 07/21/17 02:08:02 PM
#50678   It's back but it is really a good Doc Hollywood 07/21/17 02:05:57 PM
#50677   NITE flashed 300k plus then removed it. 80k whento 07/21/17 02:00:15 PM
#50676   $0.02 very soon! Ken1998 07/21/17 02:00:07 PM
#50675   Nice...HOD moved to the Bid. Libra59 07/21/17 01:58:32 PM
#50674   Nice and steady here ... ARYC kairos 07/21/17 01:57:20 PM
#50673   Now bid support, ask moving up marginally - Libra59 07/21/17 01:51:47 PM
#50672   Here we go..thin til .02 Braden32601 07/21/17 01:51:28 PM
#50671   150k showing to .017 Doc Hollywood 07/21/17 01:48:18 PM
#50670   I like how their latest tweet regarding RRBB caryS4 07/21/17 01:46:58 PM
#50669   Ask moved down, now back and forth. Libra59 07/21/17 01:45:14 PM